Skip to content

Follicular Flushing in Patients With Suboptimal Responses

Effect of Follicular Flushing on the Ongoing Pregnancy Rate in Patients Who Developed Four or Fewer Follicles of 14mm Following Standard Ovarian Stimulation for In-vitro Fertilization Treatment - A Randomized Controlled Trial.

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02277210
Enrollment
4
Registered
2014-10-28
Start date
2014-10-31
Completion date
2018-06-02
Last updated
2021-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Brief summary

The aim of the present study is to determine the effect of follicular flushing on the ongoing pregnancy rate in patients who developed four or fewer follicles of 14mm following standard ovarian stimulation for IVF.

Detailed description

Oocyte aspiration under the guidance of transvaginal ultrasound is an integral part in IVF treatment. Follicular flushing has been advocated. However, subsequent data from randomized trials failed to demonstrate any benefits with routine follicular flushing in normally responding patients. Instead, it has been shown to prolong the operating time, increase the procedure-related pain and analgesics requirement. Most of the IVF centers no longer perform routine follicular flushing in normally responding patients. The potential role of follicular flushing in patients with a limited number of developing follicles is conflicting based on the recently published randomized trials. The aim of the present study is to determine the effect of follicular flushing on the ongoing pregnancy rate in patients who developed four or fewer follicles of 14mm following standard ovarian stimulation for IVF.

Interventions

OTHERFlushing

aspiration of follicles that are larger than 10 mm on both sides followed by follicular flushing for up to 4 times. Follicular fluid and flushing will be examined by the embryologists to identify any oocytes.

Sponsors

The University of Hong Kong
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
No minimum to 42 Years
Healthy volunteers
No

Inclusion criteria

1. Age of women \<43 years 2. Normal uterine cavity on saline sonogram 3. Endometrial thickness \>=8mm on the day of hCG

Exclusion criteria

1. Planned not to have fresh embryo transfer 2. Cycle cancelled prior to hCG administration 3. Natural cycle IVF 4. Presence of hydrosalpinges on scanning which are not surgically treated 5. Presence of endometrial polyps on scanning 6. Undergoing preimplantation genetic diagnosis

Design outcomes

Primary

MeasureTime frame
ongoing pregnancy rate10 weeks of gestation

Secondary

MeasureTime frame
number of oocytes retrievedon the day of retrieval
number of embryo available for transferon the day of embryo transfer
clinical pregnancy rate6 weeks of gestation
operation time of the retrievalon the day of retrieval
pain score of retrievalon the day of retrieval

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026